ask="0.590"
ask_size="1400"
average_daily_volume="575158"
bid="0.450"
bid_size="9900"
book_value="0.632"
change="-0.020"
change_from_200_day_moving_average="0.033"
change_from_50_day_moving_average="-0.034"
change_from_52_week_high="-0.875"
change_From_52_week_low="0.214"
change_in_percent="-3.557%"
close="0.545"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.672"
ebitda="-18.47M"
eps_estimate_current_year="-0.780"
eps_estimate_next_quarter="0.000"
eps_estimate_next_year="-0.570"
ex_dividend_date="N/A"
float_shares="29692000"
high="0.600"
high_52_weeks="1.420"
last_trade_date="2/28/2017"
last_trade_price="0.545"
last_trade_size="927"
last_trade_time="4:00pm"
low="0.542"
low_52_weeks="0.331"
market_capitalization="16.40M"
moving_average_200_day="0.512"
moving_average_50_day="0.579"
name="OncoGenex Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="0.900"
open="0.600"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="+6.464%"
percent_change_from_50_day_moving_average="-5.844%"
percent_change_from_52_week_high="-61.617%"
percent_change_from_52_week_low="+64.653%"
previous_close="0.565"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.894"
price_per_sales="3.359"
revenue="5.06M"
shares_outstanding="30086000"
short_ratio="1.110"
stock_exchange="NCM"
symbol="OGXI"
volume="217890"
weeks_range_52="0.331 - 1.420"
